Literature DB >> 9489652

Ovarian function after bone marrow transplantation during childhood.

E Thibaud1, K Rodriguez-Macias, C Trivin, H Espérou, J Michon, R Brauner.   

Abstract

Ovarian failure is often brought about by the conditioning protocol used for bone marrow transplantation (BMT). We monitored ovarian function in 31 girls conditioned for BMT at 10.3 +/- 0.6 (s.e., 3.2-17.5) years by chemotherapy alone (group 1, n = 8) or chemotherapy plus body irradiation (12 Gy, fractionated in group 2, n = 9, or 10 Gy single total body in group 3, n = 7, and 5 or 6 Gy single thoraco-abdominal in group 4, n = 7, irradiation) at 13.4 +/- 0.4 (11.7-18.6) years. Breast development was normal (n = 11), did not occur (n = 14), or did not progress spontaneously (n = 2) after BMT. The other four girls who menstruated before BMT had permanent amenorrhea. Basal plasma gonadotropin concentrations were measured in 29; follicle-stimulating hormone was increased in them all and luteinizing hormone in 23. At the last clinical evaluation at 16.3 +/- 0.4 (12.1-21.6) years, 23 girls had complete ovarian failure, two had partial ovarian failure, and six had normal ovarian function. Three of these were the youngest group 1 patients and those who had not received busulfan. We conclude that conditioning for BMT given during childhood frequently prevents normal estrogen secretion at puberty. Adequate substitutive treatment may be necessary to induce growth acceleration and sexual development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489652     DOI: 10.1038/sj.bmt.1701075

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  21 in total

Review 1.  Childhood to adult transition and long-term follow-up after blood and marrow transplantation.

Authors:  M C Cupit; C Duncan; B N Savani; S K Hashmi
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

2.  Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.

Authors:  Yee Chung Cheng; Mariko Takagi; Andrea Milbourne; Richard E Champlin; Naoto T Ueno
Journal:  Oncologist       Date:  2012-01-26

3.  Immunoisolating poly(ethylene glycol) based capsules support ovarian tissue survival to restore endocrine function.

Authors:  James R Day; Anu David; Alexa L Cichon; Tanay Kulkarni; Marilia Cascalho; Ariella Shikanov
Journal:  J Biomed Mater Res A       Date:  2018-02-05       Impact factor: 4.396

Review 4.  Pediatric and young adult patients and oncofertility.

Authors:  Katherine E Dillon; Clarisa R Gracia
Journal:  Curr Treat Options Oncol       Date:  2012-06

5.  Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report.

Authors:  Serena Dovey; Lakshmanan Krishnamurti; Joseph Sanfilippo; Sriya Gunawardena; Patricia Mclendon; Mary Campbell; Sandra Alway; Brenda Efymow; Clarisa Gracia
Journal:  J Assist Reprod Genet       Date:  2012-01-05       Impact factor: 3.412

6.  The Effects of Negative Elements in Environment and Cancer on Female Reproductive System.

Authors:  Jiangxue Qu; Yuehan Li; Shujie Liao; Jie Yan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Xenobiotic effects on ovarian preantral follicles.

Authors:  Connie J Mark-Kappeler; Patricia B Hoyer; Patrick J Devine
Journal:  Biol Reprod       Date:  2011-06-22       Impact factor: 4.285

Review 8.  Surviving childhood cancer: the impact on life.

Authors:  Robert E Goldsby; Denah R Taggart; Arthur R Ablin
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

9.  Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy.

Authors:  Malgorzata E Skaznik-Wikiel; Megan M McGuire; Meena Sukhwani; Julia Donohue; Tianjiao Chu; Thomas C Krivak; Aleksandar Rajkovic; Kyle E Orwig
Journal:  Fertil Steril       Date:  2013-02-26       Impact factor: 7.329

10.  Endocrine sequelae of cancer and cancer treatments.

Authors:  Charles J Stava; Camilo Jimenez; Rena Vassilopoulou-Sellin
Journal:  J Cancer Surviv       Date:  2007-11-20       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.